Relevant BNF section: 18.104.22.168
The antibiotic co-amoxiclav (Augmentin - SmithKline Beecham) was first launched in the UK in 1981. When we reviewed it in 1982, we recommended it as second-line treatment for urinary infections and concluded that its place in other infections was unclear.1 Here we reassess the value of co-amoxiclav.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.